GLP-2 does not significantly change lymph TG concentration, TG output (mL TG per hour) or chylomicron size (TG:apoB48) compared to placebo control, rather it increases the cumulative increase in lymph TG in 60 min (Stahel et al., 2019)
Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment
doi: 10.3389/fendo.2021.620566 3 PopkinBMDuSGreenWDBeckMAAlgaithTHerbstCHet al
When the dose changes, the units change, and you need a deliberate moment of updating your routine, not hoping you remember to do more math at the right time
Low testosterone may result in a loss of confidence and lack of motivation
The limited research on GLP-1s and eating disorders While theres no direct evidence that GLP-1s treat BED yet, observational studies do show that they reduce binge eating behaviors even when people dont lose weight